VACBF (Nykode Therapeutics AS) Accumulated Depreciation : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Nykode Therapeutics AS's annual accumulated depreciation increased from Dec. 2021 ($-1.22 Mil) to Dec. 2022 ($-3.01 Mil) and increased from Dec. 2022 ($-3.01 Mil) to Dec. 2023 ($-5.13 Mil).

Nykode Therapeutics AS Accumulated Depreciation Historical Data

The historical data trend for Nykode Therapeutics AS's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Accumulated Depreciation Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.19

-0.49

-1.22

-3.01

-5.13

Nykode Therapeutics AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-5.13	-	-	-

Nykode Therapeutics AS Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Nykode Therapeutics AS Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

NYKD:Norway 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.